Canada's procurement department is scrambling to source smaller syringes for Pfizer-BioNTech COVID-19 vaccine, anticipating that Health Canada will agree to change the label to say each vial of the precious substance contains six doses instead of five.
Pfizer formally requested the change Jan. 22, and Health Canada's regulatory team that approved the vaccine for use Dec. 9 is now considering the new material.
If the label is amended, Pfizer will ship fewer vials to Canada overall because Canada's contract with the vaccine-maker is based on 40 million doses, not vials.
That sixth dose was a surprise find by medical professionals who found using special syringes could extract the extra dose.
But those syringes are not common and have become the latest COVID-19 hot commodity after both Europe and the United States agreed to the label change earlier this month.
A spokeswoman for Procurement Minister Anita Anand says more than 87 million of the smaller syringes have been ordered but can't say how many have been delivered or when the rest will arrive.
We share the urgency of Cdns to ensure vaccine access as rapidly as possible.šØš¦ is on track to receive doses for all Cdns who wish to be vaccinated by end of Sept.
ā Anita Anand (@AnitaOakville) January 22, 2021
I am in touch with Pfizer on a daily basis incl. this evening. We're on it & will stay on it until the job is done. https://t.co/z6re02grNm pic.twitter.com/bKQDQC4UWQ
